High glucose-induced inhibition of 2-deoxyglucose uptake is mediated by cAMP, protein kinase C, oxidative stress and mitogen-activated protein kinases in mouse embryonic stem cells

Clin Exp Pharmacol Physiol. 2006 Mar;33(3):211-20. doi: 10.1111/j.1440-1681.2006.04348.x.

Abstract

Abnormally high glucose levels may play an important role in early embryo development and function. In the present study, we investigated the effect of high glucose on 2-deoxyglucose (2-DG) uptake and its related signalling pathway in mouse embryonic stem (ES) cells. 2. 2-Deoxyglucose uptake was maximally inhibited by 25 mmol/L glucose after 24 h treatment. However, 25 mmol/L mannitol and dextran did not affect 2-DG uptake. Indeed, 25 mmol/L glucose decreased GLUT-1 mRNA and protein levels. The glucose (25 mmol/L)-induced inhibition of 2-DG uptake was blocked by pertussis toxin (a G(i)-protein inhibitor; 2 ng/mL), SQ 22,536 (an adenylate cyclase inhibitor; 10(-6) mol/L) and the protein kinase (PK) A inhibitor myristoylated PKI amide-(14-22) (10(-6) mol/L). Indeed, 25 mmol/L glucose increased intracellular cAMP content. 3. Furthermore, 25 mmol/L glucose-induced inhibition of 2-DG uptake was prevented by 10(-4) mol/L neomycin or 10(-6) mol/L U 73,122 (phospholipase C (PLC) inhibitors) and staurosporine or bisindolylmaleimide I (protein kinase (PK) C inhibitors). At 25 mmol/L, glucose increased translocation of PKC from the cytoplasmic fraction to the membrane fraction. The 25 mmol/L glucose-induced inhibition of 2-DG uptake and GLUT-1 protein levels was blocked by SQ 22,536, bisindolylmaleimide I or combined treatment. In addition, 25 mmol/L glucose increased cellular reactive oxygen species and the glucose-induced inhibition of 2-DG uptake were blocked by the anti-oxidants N-acetylcysteine (NAC; 10(-5) mol/L) or taurine (2 yen 10(-3) mol/L). 4. Glucose (25 mmol/L) activated p38 mitogen-activated protein kinase (MAPK) and p44/42 MAPK. Staurosporine (10(-6) mol/L), NAC (10(-5) mol/L) and PD 98059 (10(-7) mol/L) attenuated the phosphorylation of p44/42 MAPK. Both SB 203580 (a p38 MAPK inhibitor; 10(-7) mol/L) and PD 98059 (a p44/42 MAPK inhibitor; 10(-7) mol/L) blocked 25 mmol/L glucose-induced inhibition of 2-DG uptake. 5. In conclusion, high glucose inhibits 2-DG uptake through cAMP, PLC/PKC, oxidative stress or MAPK in mouse ES cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Animals
  • Antimetabolites / antagonists & inhibitors
  • Antimetabolites / metabolism*
  • Blotting, Western
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Cyclic AMP / physiology*
  • Cytosol / metabolism
  • Deoxyglucose / antagonists & inhibitors
  • Deoxyglucose / metabolism*
  • Fluorescent Antibody Technique
  • Glucose / pharmacology
  • Hydrogen Peroxide / pharmacology
  • Lipid Peroxidation / drug effects
  • Mice
  • Mitogen-Activated Protein Kinases / physiology*
  • Oxidative Stress / physiology*
  • Protein Kinase C / physiology*
  • RNA / biosynthesis
  • RNA / isolation & purification
  • Reactive Oxygen Species
  • Stem Cells / enzymology
  • Stem Cells / metabolism
  • Stem Cells / physiology*

Substances

  • Antimetabolites
  • Reactive Oxygen Species
  • RNA
  • Deoxyglucose
  • Hydrogen Peroxide
  • Cyclic AMP
  • Protein Kinase C
  • Mitogen-Activated Protein Kinases
  • Alkaline Phosphatase
  • Glucose